(Q40190332)

18 September 2017

title

The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer (English)

1 reference

18 September 2017

H Ying

1

1 reference

18 September 2017

M C Willingham

series ordinal

2

1 reference

18 September 2017

S-Y Cheng

series ordinal

3

1 reference

18 September 2017

language of work or name

English

0 references

publication date

23 July 2007

1 reference

18 September 2017

1 reference

18 September 2017

volume

27

1 reference

18 September 2017

issue

6

1 reference

18 September 2017

page(s)

823-830

1 reference

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

Expanding functional diversity of the coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

Direct control of cell cycle gene expression by proto-oncogene product ACTR, and its autoregulation underlies its transforming activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

Thyroid hormone resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

SRC-3/AIB1: transcriptional coactivator in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

inferred from DOI database lookup

7 January 2021

based on heuristic

Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

inferred from DOI database lookup

7 January 2021

based on heuristic

SRC-3 is required for prostate cancer cell proliferation and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210680

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1210680

1 reference

Dimensions Publication ID

18 September 2017

1008854830

0 references

1 reference